Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters

Publication year range
1.
J Appl Microbiol ; 126(1): 230-241, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30267608

ABSTRACT

AIMS: Atopic dermatitis (AD) is a chronic inflammatory skin disease, with a steadily increasing prevalence. Lactic acid bacteria (LAB) have been widely used in the food industry and are an attractive option for preventing and treating allergic skin diseases. We previously isolated new LABs including Lactococcus lactis KR-050L from Gajuknamu kimchi, and showed the anti-inflammatory effects of extract of L. lactis KR-050L culture broth (LLK). In this study, we investigated the effects of LLK on AD. METHODS AND RESULTS: For the in vitro study, we used human keratinocytes (HaCaT) and mast cells (RBL-2H3). In vivo study, we investigated the effects of LLK on Dermatophagoides farinae extract (DFE) and 2,4-dinitrochlorobenzene (DNCB)-induced atopic skin inflammation in mice. LLK suppressed expression of pro-inflammatory cytokines and chemokines by down-regulation of p38 MAPK, STAT1 and nuclear translocation of NF-κB in keratinocytes. Topical application of LLK suppressed AD symptoms based on reduction in ear thickness, serum IgE levels and immune cell infiltration. Furthermore, LLK inhibited serum histamine levels and mast cells infiltration in vivo, and reduced mast cells activation in vitro. CONCLUSIONS: These results suggest that LLK inhibits AD symptoms through inhibition of keratinocytes and mast cells activation. SIGNIFICANCE AND IMPACT OF THE STUDY: LLK is a potential therapeutic candidate for AD treatment.


Subject(s)
Dermatitis, Atopic/metabolism , Keratinocytes/drug effects , Lactococcus lactis/chemistry , Mast Cells/drug effects , Pyroglyphidae/chemistry , Animals , Biological Products/pharmacology , Cytokines/analysis , Cytokines/metabolism , Keratinocytes/metabolism , Mast Cells/metabolism
2.
Epidemiol Infect ; 145(15): 3226-3242, 2017 11.
Article in English | MEDLINE | ID: mdl-28988544

ABSTRACT

Respiratory syncytial virus (RSV) can cause serious respiratory infections, second only to influenza virus. In order to know RSV's genetic changes we examined 4028 respiratory specimens from local hospital outpatients in Gyeonggi Province, South Korea over six consecutive years by real-time one-step RT-PCR; 183 patients were positive for RSV infection. To investigate the specific distribution of RSV genotypes, we performed partial sequencing of the glycoprotein gene. Of the 131 RSV-A specimens sequenced, 61 (43·3%) belonged to the ON1 genotype, 66 (46·8%) were NA1 genotype, 3 (2·1%) were GA5 genotype, and 1 (0·7%) belonged to the GA1 genotype. Of the 31 RSV-B specimens sequenced, 29 were BA9 genotype (87·9%) and 2 were BA10 genotype (6·1%). The most common clinical symptoms were fever, cough, nasal discharge, and phlegm; multiple logistic regression analysis showed that RSV-positive infection on pediatric patients was strongly associated with cough (OR = 2·8, 95% CI 1·6-5·1) and wheezing (OR = 2·8, 95% CI 1·7-4·4). The ON1 genotype was significantly associated with phlegm (OR = 11·8, 95% CI 3·8-46·7), while the NA1 genotype was associated with the pediatric patients' gender (males, OR = 2·4, 95% CI 1·1-5·4) and presence of chills (OR = 5·1, 95% CI 1·1-27·2). RSV subgroup B was showed association with nasal obstruction (OR = 4·6, 95% CI 1·2-20·0). The majority of respiratory virus coinfections with RSV were human rhinovirus (47·2%). This study contributes to our understanding of the molecular epidemiological characteristics of RSV, which promotes the potential for improving RSV vaccines.


Subject(s)
Respiratory Syncytial Virus Infections/virology , Respiratory Syncytial Viruses/genetics , Adolescent , Adult , Age Factors , Aged , Child , Child, Preschool , Female , Genotype , Humans , Infant , Infant, Newborn , Male , Middle Aged , Phylogeny , Republic of Korea/epidemiology , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus Infections/pathology , Sex Factors , Young Adult
3.
Epidemiol Infect ; 144(13): 2759-64, 2016 10.
Article in English | MEDLINE | ID: mdl-26830365

ABSTRACT

An acute gastroenteritis (AGE) outbreak was reported in May 2013 in Gyeonggi Province, South Korea. Eight students who had eaten breakfast on 21 May 2013 at a high-school restaurant exhibited AGE symptoms. Our case-control study showed that a strong association was observed between AGE symptoms and fermented oyster consumption. Virological studies also indicated that noroviruses (NoVs) were detected from both clinical samples and fermented oyster samples, and multiple different genotypes (genogroups GII.4, GII.11 and GII.14) of NoVs were present in both samples. The nucleotide sequence similarity between the strains found in the clinical samples and those in the fermented oysters was more than 99·5%. Therefore, to prevent further outbreaks, proper management of raw oysters is necessary and the food industry should be aware of the risk of viral gastroenteritis posed by fermented oysters contaminated with NoVs.


Subject(s)
Caliciviridae Infections/epidemiology , Disease Outbreaks , Food Microbiology , Gastroenteritis/epidemiology , Norovirus/physiology , Ostreidae/virology , Shellfish/virology , Acute Disease , Adolescent , Animals , Caliciviridae Infections/virology , Capsid Proteins/genetics , Case-Control Studies , Fermentation , Gastroenteritis/virology , Humans , Phylogeny , Republic of Korea/epidemiology , Sequence Analysis, RNA
4.
Epidemiol Infect ; 142(12): 2604-9, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24534556

ABSTRACT

Epidemiological and virological studies indicate that noroviruses-contaminated groundwater was the primary source of four acute gastroenteritis outbreaks in South Korea between 2008 and 2012. Furthermore, cabbage kimchi was first identified as the vehicle of transmission between groundwater and infected patients in an outbreak in 2011. The proper treatment of groundwater sources prior to use for drinking or in food preparation is necessary to prevent further outbreaks.


Subject(s)
Brassica , Caliciviridae Infections/epidemiology , Caliciviridae Infections/virology , Disease Outbreaks , Gastroenteritis/epidemiology , Gastroenteritis/virology , Norovirus/isolation & purification , Water Microbiology , Acute Disease , Female , Humans , Male , Molecular Sequence Data , Norovirus/genetics , Phylogeny , Republic of Korea/epidemiology
5.
S Afr Med J ; 113(2): 84-90, 2023 02 01.
Article in English | MEDLINE | ID: mdl-36757071

ABSTRACT

BACKGROUND: Self-monitoring of blood glucose (SMBG) is a widely accepted standard of practice for management of insulin-dependentdiabetes, yet is largely unavailable in rural sub-Saharan Africa (SSA). This prospective cohort study is the first known report ofimplementation of SMBG in a rural, low-income country setting. OBJECTIVES: To evaluate adherence and change in clinical outcomes with SMBG implementation at two rural hospitals in Neno, Malawi. METHODS: Forty-eight patients with type 1 and insulin-dependent type 2 diabetes were trained to use glucometers and logbooks. Participantsmonitored preprandial glucose daily at rotating times and overnight glucose once a week. Healthcare providers were trained to evaluateglucose trends, and adjusted insulin regimens based on results. Adherence was measured as the frequency with which patients checked anddocumented blood glucose at prescribed times, while clinical changes were measured by change in glycated haemoglobin (HbA1c) over a6-month period. RESULTS: Participants brought their glucometers and logbooks to the clinic 95 - 100% of the time. Adherence with measuring glucose valuesand recording them in logbooks eight times a week was high (mean (standard deviation) 69.4% (15.7) and 69.0% (16.6), respectively). MeanHbA1c decreased from 9.0% (75 mmol/mol) at enrolment to 7.8% (62 mmol/mol) at 6 months (mean difference 1.2% (95% confidenceinterval (CI) 0.6 - 2.0; p=0.0005). The difference was greater for type 1 diabetes (1.6%; 95% CI 0.6 - 2.7; p=0.0031) than for type 2 diabetes(0.9%; 95% CI 0.1 - 1.9; p=0.0630). There was no documented increase in hypoglycaemic events, and no hospitalisations or deaths occurred. CONCLUSION: SMBG is feasible for patients with insulin-dependent diabetes in a rural SSA population, and may be associated with improvedHbA1c levels. Despite common misconceptions, all patients, regardless of education level, can benefit from SMBG. Further research onlong-term retention of SMBG activities and the benefits of increasing frequency of monitoring is warranted.


Subject(s)
Diabetes Mellitus, Type 1 , Diabetes Mellitus, Type 2 , Noncommunicable Diseases , Humans , Blood Glucose , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 2/epidemiology , Malawi/epidemiology , Prospective Studies , South Africa , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Blood Glucose Self-Monitoring/methods
6.
Br J Anaesth ; 108(6): 990-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22434266

ABSTRACT

BACKGROUND: Patients undergoing Caesarean delivery under inhalation anaesthesia are at a high risk of awareness, especially in the period before delivery. We assessed the effects of pre-exposure to sevoflurane on the bispectral index (BIS) in the interval before delivery. METHODS: Sixty-four patients undergoing elective Caesarean delivery were randomly assigned to receive 1.0-1.1 vol% (control 1) or 1.2-1.3 vol% (control 2) end-tidal sevoflurane, or the same concentrations of end-tidal sevoflurane combined with pre-exposure to 1 vol% sevoflurane for the last 1 min of the preoxygenation period (the preSevo 1 and preSevo 2 groups, respectively). We assessed BIS values, arterial pressure, and heart rate at the time of induction; before intubation; and upon skin incision, uterine incision, and delivery. We also determined the maternal incidence of intraoperative awareness and the neonatal Apgar scores, and conducted umbilical blood gas analysis. RESULTS: At skin incision, BIS values were significantly lower in the preSevo 1 group than in the control 1 group [50 (13) vs 72 (8), P<0.001] and in the preSevo 2 group than in the control 2 group [44 (11) vs 67 (10), P<0.001]. The mean BIS values in the preSevo 1 and 2 groups were maintained below 60 in the period before delivery. No other parameter differed among groups, and no patient exhibited intraoperative awareness. CONCLUSIONS: Pre-exposure to low concentrations of sevoflurane reduced BIS values in the interval before delivery, suggesting that this approach may reduce the risk of maternal awareness. Clinical Research Information Service (code KCT0000069, http://cris.cdc.go.kr).


Subject(s)
Anesthesia, Obstetrical , Anesthetics, Inhalation/pharmacology , Cesarean Section , Electroencephalography/drug effects , Methyl Ethers/pharmacology , Adult , Anesthesia, General , Awareness , Blood Pressure/drug effects , Female , Humans , Pregnancy , Prospective Studies , Sevoflurane
7.
Br J Anaesth ; 107(5): 769-73, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21862492

ABSTRACT

BACKGROUND: Estimation of teeth-to-vallecula distance would facilitate the selection of properly sized oropharyngeal airways in young children. The aims of the present study were to measure the teeth-to-vallecula distance and to create an algorithm to predict this distance based on anatomical landmarks and patient characteristics in children. METHODS: Two hundred children, aged 1-9 yr, undergoing elective surgery were investigated. After induction of general anaesthesia, the distance from the teeth to the vallecula was measured using a laryngoscope with a straight blade. After intubation, the distances from the mouth angle to the mandible angle and the tragus of the ear were measured with a tape measure. RESULTS: The teeth-to-vallecula distance was significantly correlated with the age, weight, height, and external measurements (P<0.001). By stepwise multiple linear regression analysis, a formula was obtained for the teeth-to-vallecula distance (cm) = 3.998 + 0.017 × age (months)+the mouth-to-mandible distance × 0.286 with a high coefficient of determination (r²=0.764). CONCLUSIONS: The teeth-to-vallecula distance can be predicted using the age and the mouth-to-mandible distance in young children.


Subject(s)
Body Weights and Measures , Intubation, Intratracheal , Oropharynx/anatomy & histology , Age Factors , Algorithms , Body Height , Body Weight , Child , Child, Preschool , Female , Humans , Infant , Laryngoscopes , Male , Mandible/anatomy & histology , Mouth/anatomy & histology , Tooth
8.
Public Health Action ; 9(4): 142-147, 2019 Dec 21.
Article in English | MEDLINE | ID: mdl-32042605

ABSTRACT

SETTING: Three district hospitals (DHs) and seven health centers (HCs) in rural Rwanda. OBJECTIVE: To describe follow-up and treatment outcomes in stage 1 and 2 hypertension patients receiving care at HCs closer to home in comparison to patients receiving care at DHs further from home. DESIGN: A retrospective descriptive cohort study using routinely collected data involving adult patients aged ⩾18 years in care at chronic non-communicable disease clinics and receiving treatment for hypertension at DH and HC between 1 January 2013 and 30 June 2014. RESULTS: Of 162 patients included in the analysis, 36.4% were from HCs. Patients at DHs travelled significantly further to receive care (10.4 km vs. 2.9 km for HCs, P < 0.01). Odds of being retained were significantly lower among DH patients when not adjusting for distance (OR 0.11, P = 0.01). The retention effect was consistent but no longer significant when adjusting for distance (OR 0.18, P = 0.10). For those retained, there was no significant difference in achieving blood pressure targets between the DHs and HCs. CONCLUSION: By removing the distance barrier, decentralizing hypertension management to HCs may improve long-term patient retention and could provide similar hypertension outcomes as DHs.

9.
Public Health Action ; 7(3): 231-236, 2017 Sep 21.
Article in English | MEDLINE | ID: mdl-29201658

ABSTRACT

Setting: Programmes that integrate mental health care into primary care settings could reduce the global burden of mental disorders by increasing treatment availability in resource-limited settings, including Rwanda. Objective: We describe patient demographics, service use and retention of patients in care at health centres (HC) participating in an innovative primary care integration programme, compared to patients using existing district hospital-based specialised out-patient care. Design: This was a retrospective cohort study using routinely collected data from six health centres and one district hospital from October 2014 to March 2015. Results: Of 709 patients, 607 were cared for at HCs; HCs accounted for 88% of the total visits for mental disorders. Patients with psychosis used HC services more frequently, while patients with affective disorders were seen more frequently at the district hospital. Of the 68% of patients who returned to care within 90 days of their first visit, 76% had a third visit within a further 90 days. There were no significant differences in follow-up rates between clinical settings. Conclusion: This study suggests that a programme of mentorship for primary care nurses can facilitate the decentralisation of out-patient mental health care from specialised district hospital mental health services to HCs in rural Rwanda.


Contexte : Les programmes qui intègrent les soins de santé mentale dans les structures de soins de santé primaires pourraient réduire le fardeau mondial des troubles mentaux en augmentant la disponibilité du traitement dans des contextes de ressources limitées, notamment au Rwanda.Objectif : Nous décrivons les caractéristiques démographiques des patients, leur utilisation des services et la rétention des patients en traitement dans les centres de santé (HC) participant à un programme innovant d'intégration dans les soins de santé primaires, comparés aux patients recourant aux consultations spécialisées existantes, basées dans les hôpitaux de district.Schéma : Une étude rétrospective de cohorte basée sur des données recueillies en routine dans six centres de santé et dans un hôpital de district, entre octobre 2014 et mars 2015.Résultats : De 709 patients, 607 ont été soignés dans les HC et les HC ont totalisé 88% de l'ensemble des consultations pour troubles mentaux. Les patients atteints de psychose ont plus souvent utilisé les services des HC, tandis que les patients atteints de troubles affectifs ont été plus souvent vus à l'hôpital de district. De 68% des patients qui sont revenus dans les 90 jours suivant leur première consultation, 76% ont eu une troisième consultation au cours des 90 jours suivants. Il n'y a pas eu de différences significatives en termes de taux de suivi entre les deux contextes cliniques.Conclusion : Cette étude suggère qu'un programme de tutorat destiné aux infirmiers de soins de santé primaires peut faciliter la décentralisation de la prise en charge de la santé mentale en consultation externe des services de santé mentale des hôpitaux spécialisés de district vers les HC dans le Rwanda rural.


Marco de referencia: Los programas que integran la atención de la salud mental al entorno de la atención primaria podrían reducir la carga mundial de morbilidad por trastornos mentales, al aumentar la disponibilidad del tratamiento en los medios con escasos recursos, por ejemplo en Rwanda.Objetivo: Se describen las características demográficas, la utilización de los servicios y la retención en la atención, de los pacientes atendidos en los centros de salud que participan en un programa innovador de atención primaria y se comparan con los pacientes que acuden a la consulta ambulatoria especializada que se presta en un hospital distrital.Método: Fue este un estudio de cohortes retrospectivo a partir de los datos recogidos de manera sistemática en seis centros de salud y un hospital distrital, de octubre del 2014 a marzo del 2015.Resultados: De los 709 pacientes, se atendieron 607 en los centros de salud y estos centros realizaron el 88% del total de consultas por trastornos mentales. Los pacientes con trastornos psicóticos utilizaban con mayor frecuencia los servicios en los centros de salud, pero los pacientes con trastornos del afecto se atendían con mayor frecuencia en el hospital distrital. El 68% de los pacientes regresaron al servicio de atención en los 90 días que siguieron a su primera consulta y el 76% de ellos acudió a una tercera consulta en los siguientes 90 días. No se observaron diferencias significativas en las tasas de seguimiento en los diferentes entornos clínicos.Conclusión: Los resultados del presente estudio ponen de manifiesto que un programa tutorial dirigido al personal de enfermería de los centros de atención primaria puede facilitar la descentralización de la atención ambulatoria de los pacientes con trastornos de salud mental, desde el hospital distrital con servicios especializados hacia los centros de salud en zonas rurales de Rwanda.

10.
Thromb Res ; 91(1): 33-8, 1998 Jul 01.
Article in English | MEDLINE | ID: mdl-9700851

ABSTRACT

The antiplatelet and antithrombotic effects of the oral combination treatment of ticlopidine and Ginkgo biloba extract (EGb 761) were studied in normal and thrombosis-induced rats. The ex vivo inhibitory effect on ADP-induced platelet aggregation of a small dose of ticlopidine (50 mg/kg/day) in combination with EGb 761 (40 mg/kg/day) was comparable to a larger dose of only ticlopidine (200 mg/kg/day). Bleeding time was also prolonged by 150%. Thrombus weight was also consistently decreased by a combination of ticlopidine and EGb 761 in an arterio-venous shunt model at two doses of ticlopidine (50 mg/kg) plus EGb 761 (20 mg/kg) and ticlopidine (50 mg/kg) plus EGb 761 (40 mg/kg). A combinatory treatment in acute thrombosis model in mice also showed a higher recovery than a single treatment.


Subject(s)
Blood Platelets/drug effects , Fibrinolytic Agents/pharmacology , Flavonoids/pharmacology , Hemostatics/pharmacology , Plant Extracts , Platelet Aggregation Inhibitors/pharmacology , Ticlopidine/pharmacology , Animals , Collagen/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Epinephrine/pharmacology , Flavonoids/administration & dosage , Ginkgo biloba , Hemostatics/administration & dosage , Mice , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/administration & dosage , Rats , Thrombosis/chemically induced , Ticlopidine/administration & dosage
11.
J Pharm Pharmacol ; 53(2): 197-204, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11273016

ABSTRACT

The anti-fibrotic effects of a hot-water extract form the traditional Chinese medicinal herb Salvia miltiorrhiza (Labiatae) on liver fibrosis induced by biliary obstruction was studied in rats. Liver fibrosis was induced in male Sprague-Dawley rats by bile duct ligation and scission (BDL). After surgery, the hot-water extract of S. miltiorrhiza roots (100 mg kg(-1), p.o.) was administered daily for 28 days. The concentrations of aspartate transaminase, alanine transaminase, alkaline phosphatase, total bilirubin and total cholesterol in serum and hydroxyproline and malondialdehyde contents in liver were significantly increased in BDL rats. Treatment with the extract of S. miltiorrhiza significantly reduced (P < 0.01) the serum aspartate transaminase, alanine transaminase, alkaline phosphatase, and total cholesterol concentrations in BDL rats. The liver hydroxyproline content in BDL rats treated with extract was also reduced to 68% of that in BDL control rats (P < 0.01). The liver malondialdehyde content in BDL rats treated with the extract was also reduced to 47% of that in BDL control rats (P < 0.01). The morphological characteristics of fibrotic livers were improved in BDL rats treated with extract. Immunohistochemical examination of fibrotic liver showed that the extract of S. miltiorrhiza markedly reduced protein expression of alpha-smooth muscle cell-like actin, which indicates that hepatic stellate cell activation was inhibited during liver fibrosis development. The results indicate that the hot-water extract of S. miltiorrhiza roots inhibits fibrosis and lipid peroxidation in rats with liver fibrosis induced by biliary obstruction.


Subject(s)
Cholestasis, Intrahepatic/complications , Liver Cirrhosis/drug therapy , Plant Extracts/therapeutic use , Plants, Medicinal/chemistry , Animals , Carbon Tetrachloride Poisoning/drug therapy , Carbon Tetrachloride Poisoning/pathology , Collagen/biosynthesis , Hydroxyproline/metabolism , Immunohistochemistry , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/metabolism , Liver/pathology , Liver Cirrhosis/etiology , Liver Cirrhosis/pathology , Liver Function Tests , Male , Plant Roots/chemistry , Rats , Rats, Sprague-Dawley , Water
12.
J Parasitol ; 86(2): 333-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10780554

ABSTRACT

A gene encoding a cysteine proteinase from Paragonimus westermani has been cloned and expressed in Escherichia coli. The cysteine proteinase cDNA fragment was amplified by reverse transcription-polymerase chain reaction (RT-PCR) using degenerate oligonucleotide primers derived from the conserved active site of the cysteine proteinase. The 5' and 3' regions of the gene were amplified using a PCR technique for the rapid amplification of cDNA ends. The cloned gene has an open reading frame of 687 bp and deduced amino acid sequence of 229. Sequence analysis and alignment showed significant homologies with the eukaryotic cysteine proteinases and conservation of the Cys, His, and Asp residues that form a catalytic triad. Analysis of the expressed protein on sodium dodecyl sulfate polyacrylamide gel electrophoresis showed that the molecular weight of the protein was approximately 28.5 kDa. The expressed protein reacted with the sera of patients with paragonimiasis but not with the sera of fascioliasis and clonorchiasis. These results suggest that the expressed protein may be valuable as a specific diagnostic material for the immunodiagnosis of paragonimiasis.


Subject(s)
Cysteine Endopeptidases/genetics , Paragonimus/enzymology , Paragonimus/genetics , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Blotting, Western , Cloning, Molecular , Cysteine Endopeptidases/biosynthesis , Cysteine Endopeptidases/chemistry , DNA, Complementary/chemistry , Electrophoresis, Polyacrylamide Gel , Gene Expression , Humans , Immune Sera/immunology , Molecular Sequence Data , Polymerase Chain Reaction , Sequence Alignment
13.
Arch Pharm Res ; 23(5): 501-6, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11059831

ABSTRACT

We examined the antifibrotic effect of a methanol extract from Stephania tetrandra (ST) on experimental liver fibrosis. Liver fibrosis was induced by bile duct ligation and scission (BDL/S) in rats. In BDL/S rats, activity levels of aspartate transaminase (AST), alanine transaminse (ALT), alkaline phosphatase (ALP), concentration of total bilirubin in serum, and hydroxyproline content of the liver were significantly increased. The ST treatment (either 100 mg/kg/day or 200 mg/kg/day, p.o. for 4 weeks) in BDL/S rats reduced the serum AST, ALT and ALP activity levels significantly (p< 0.01). Similarly, when compared to the control group, the concentration of hydroxyproline in the livers of the BDL/S rats treated with 100mg or 200mg ST treated rats decreased by 40% and 33% respectively, when compared to the BDL/S control group (p<0.01). The morphological characteristics of fibrotic liver that were observed in the BDL/S control group, improved in the ST treated BDL/S group. In the fibrotic liver of BDL/S rats treated with ST, a marked reduction in the numbers of alpha smooth muscle cell actin positive stellate cells was observed. These results indicate that doses of either 100 or 200 mg/kg/day of methanol extract from S. tetrandra, had an antifibrotic effect in rats with liver fibrosis induced by bile duct ligation and scission.


Subject(s)
Liver Cirrhosis, Experimental/drug therapy , Plants, Medicinal , Animals , Bile Ducts , Body Weight/drug effects , Hydroxyproline/analysis , Ligation , Liver/pathology , Liver Cirrhosis, Experimental/pathology , Male , Organ Size/drug effects , Plant Extracts/therapeutic use , Rats , Rats, Sprague-Dawley
14.
Int J Tuberc Lung Dis ; 17(6): 759-63, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23676158

ABSTRACT

SETTING: As the incidence of tuberculosis (TB) declines in high-income countries, resources to control TB are also declining. A portion of these resources are utilized for the evaluation and treatment of persons initially suspected of, but who do not actually have, TB (TB suspects). OBJECTIVE: To describe the cost of TB suspects to public health departments, and determine whether part of this cost can be averted using improved diagnostic tools. DESIGN: We evaluated resource utilization for all TB suspects as well as a random sample of TB cases managed at the Wake County public health clinic during 2008-2010. The proportion of total health department costs attributable to TB suspects was estimated. A sensitivity analysis assessed the potential impact of a rapid, accurate diagnostic test to avert suspect-associated costs. RESULTS: Of 135 patients evaluated for TB, 36 (27%) were suspects, accounting for 14% (US5,885) of the total estimated costs for managing all patients. A perfect diagnostic test with a 3-day turnaround would have averted US27,975 (53%) of the costs attributable to suspects. CONCLUSION: A substantial proportion of public health resources is utilized to manage persons whose final diagnosis is not TB. Efficient implementation of novel rapid tests could avert substantial public health costs.


Subject(s)
Diagnostic Tests, Routine/economics , Health Care Costs , Public Health/economics , Tuberculosis/economics , Adult , Aged , Diagnostic Tests, Routine/methods , Female , Humans , Male , Middle Aged , North Carolina/epidemiology , Nucleic Acid Amplification Techniques/economics , Nucleic Acid Amplification Techniques/methods , Public Health Practice/economics , Retrospective Studies , Time Factors , Tuberculosis/diagnosis , Tuberculosis/epidemiology
15.
Anaesth Intensive Care ; 39(5): 899-903, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21970136

ABSTRACT

The purpose of this study was to determine the optimum bolus dose of propofol required to provide excellent conditions for tracheal intubation following inhalational induction of anaesthesia using 5% sevoflurane without neuromuscular blockade. Twenty-eight children, aged three to seven years, requiring anaesthesia for short duration surgery were recruited. Two minutes after beginning the inhalational induction with 5% sevoflurane and 60% nitrous oxide, a predetermined dose of propofol was injected over 10 seconds. Propofol dose was determined using the Dixon's up-and-down method, starting from 3 mg/kg (0.5 mg/kg as a step size). Laryngoscopy was performed 50 seconds after propofol injection. The optimum dose of propofol required for excellent intubating conditions was 1.39 +/- 0.37 mg/kg in 50% of children during inhalation induction using 5% sevoflurane and 60% nitrous oxide in the absence of neuromuscular blocking agents. From probit analysis, the 95% effective dose of propofol was 2.33 mg/kg (95% confidence interval 1.78 to 6.21 mg/kg).


Subject(s)
Anesthetics, Inhalation , Anesthetics, Intravenous , Intubation, Intratracheal , Methyl Ethers , Neuromuscular Blockade , Propofol/administration & dosage , Blood Pressure/drug effects , Child , Child, Preschool , Dose-Response Relationship, Drug , Female , Heart Rate/drug effects , Humans , Male , Muscle Relaxation/drug effects , Nitrous Oxide , Sevoflurane
16.
Transplant Proc ; 42(5): 1959-62, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20620555

ABSTRACT

We have described herein a 39-year-old male patient with hepatitis B virus-related cirrhosis (Child class C), showing a prolonged corrected QT interval, who developed torsades de pointes (TdP) in the neohepatic stage of liver transplantation (LT). There was no arrhythmia in the pre-anhepatic and anhepatic stages. Multiple premature ventricular complexes, ventricular tachycardia, and TdP suddenly developed at 16 minutes after graft reperfusion without any prodromal arrhythmia; they persisted for 118 seconds. Laboratory tests showed that serum potassium, calcium, and magnesium concentrations of 4.7 mmol/L, 1.05 mmol/L, and 1.85 mg/dL, respectively were within normal ranges. Likely causative factors for TdP in this patient included a prolonged corrected QT interval (553 msec), a low hematocrit (21%), and a low arterial blood pressure (systolic blood pressure, 80-90 mm Hg; diastolic blood pressure; 20-26 mm Hg) in the neohepatic stage. This case demonstrated the importance of optimal maintenance of coronary perfusion, with an adequate hematocrit level and electrolyte concentrations, to prevent the development of TdP in cirrhotic patients with a prolonged corrected QT interval during LT.


Subject(s)
Hypotension/complications , Intraoperative Complications/etiology , Liver Transplantation/adverse effects , Torsades de Pointes/etiology , Adult , Diastole , Hematocrit , Hepatectomy , Hepatitis B/surgery , Humans , Hypotension/physiopathology , Liver Cirrhosis/surgery , Liver Cirrhosis/virology , Male , Torsades de Pointes/prevention & control
17.
Anesth Analg ; 90(2): 421-6, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10648332

ABSTRACT

UNLABELLED: Intrathecal neostigmine reverses mechanical allodynia in humans and animals. The efficacy of morphine in a neuropathic pain state is still controversial. This study examines the antiallodynic interaction between morphine and neostigmine in a rat model of neuropathic pain. Rats were prepared with tight ligation of left L5-6 (fifth and sixth lumbar) spinal nerves and chronic intrathecal catheter implantation. Mechanical allodynia was measured by using application of von Frey hairs to the left hindpaw. Morphine (1, 3, 10, and 30 microg) and neostigmine (0.3, 1, 3, and 10 microg) were administered intrathecally to obtain the dose-response curves and the 50% effective dose (ED(50)) for each drug. ED(50) values and fractions of the ED(50) values (1/2, 1/4, and 1/8) were administered intrathecally in an equal dose ratio to establish the ED(50). Isobolographic and fractional analyses for the drug interaction were performed. Intrathecal morphine produced a moderate antagonism of the tactile allodynia. A morphine-neostigmine combination produced a dose-dependent increase in withdrawal threshold of the lesioned hind paw with reduced side effects. Both analyses revealed a synergistic interaction after the coadministration of morphine and neostigmine. These experiments suggest that the antiallodynic action of a morphine-neostigmine combination is synergistic at the spinal level. IMPLICATIONS: This study indicates that, by using both isobolographic and fractional analyses, the antiallodynic effect of intrathecal morphine and neostigmine is synergistic when coadministered intrathecally. In a rat model of neuropathic pain, the intrathecal morphine produced a moderate antagonism on touch-evoked allodynia at the spinal level.


Subject(s)
Analgesics, Opioid/therapeutic use , Cholinesterase Inhibitors/therapeutic use , Morphine/therapeutic use , Neostigmine/therapeutic use , Pain/drug therapy , Spinal Nerves/injuries , Analgesics, Opioid/administration & dosage , Animals , Behavior, Animal/drug effects , Cholinesterase Inhibitors/administration & dosage , Dose-Response Relationship, Drug , Drug Interactions , Injections, Spinal , Ligation , Male , Morphine/administration & dosage , Neostigmine/administration & dosage , Pain Measurement , Pain Threshold/drug effects , Rats , Rats, Sprague-Dawley
18.
Anesthesiology ; 90(2): 492-9, 1999 Feb.
Article in English | MEDLINE | ID: mdl-9952157

ABSTRACT

BACKGROUND: This study determined the effect of intrathecally administered cholinesterase inhibitors, edrophonium and neostigmine, on nerve injury-induced, touch-evoked allodynia and identified the pharmacologic characteristics of this action. METHODS: Rats were prepared with tight ligation of the left L5 and L6 spinal nerves and with lumbar intrathecal catheters fitted for long-term monitoring. Edrophonium (3, 10, 30, or 100 microg) or neostigmine (0.3, 1, 3, or 10 microg) was administered intrathecally. Tactile allodynia and motor weakness were assessed. To evaluate the pharmacologic characteristics of the activity, a muscarinic receptor antagonist or a nicotinic receptor antagonist was administered intrathecally before edrophonium or neostigmine was injected. To compare the action of subtype antagonists, the M1 muscarinic receptor antagonist pirenzepine, the M2 antagonist methoctramine, the M3 antagonist 4-DAMP (diphenylacetoxy-N-methypiperidine), and the M4 antagonist tropicamide were administered intrathecally before cholinesterase inhibitors were injected. RESULTS: Intrathecal edrophonium or neostigmine produced a dose-dependent antagonism of the touch-evoked allodynia. Neostigmine resulted in a moderate effect on motor weakness at doses of 3 and 10 microg. Pretreatment with intrathecal atropine but not mecamylamine yielded a complete antagonism of the effects of the cholinesterase inhibitors. In addition, antiallodynia produced by edrophonium (100 microg) was reversed by pretreatment with methoctramine, 4-DAMP, tropicamide, and pirenzepine. In the neostigmine (10 microg) group, only the M1 antagonist pirenzepine had a moderate effect on reversal of increased allodynic threshold. CONCLUSIONS: These experiments suggest that intrathecal edrophonium or neostigmine produces an antagonism on touch-evoked allodynia at the spinal level in a rat model of neuropathic pain and that the antiallodynic action of cholinesterase inhibitors is probably mediated by a spinal muscarinic system, especially at the M1 receptor subtype.


Subject(s)
Cholinesterase Inhibitors/administration & dosage , Edrophonium/administration & dosage , Neostigmine/administration & dosage , Neuralgia/drug therapy , Parasympathomimetics/administration & dosage , Receptors, Muscarinic/physiology , Animals , Injections, Spinal , Male , Muscarinic Agonists/administration & dosage , Muscarinic Antagonists/administration & dosage , Neuralgia/physiopathology , Rats , Rats, Sprague-Dawley
19.
Anesth Analg ; 93(5): 1297-303, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11682418

ABSTRACT

UNLABELLED: Nerve ligation injury may produce a pain syndrome that includes tactile allodynia. Reversal effects on tactile allodynia have been demonstrated after the intrathecal administration of gamma-aminobutyric acid (GABA) receptor agonists or cholinesterase inhibitors in rats. We examined the drug interactions between neostigmine and muscimol or baclofen in a rat model of nerve ligation injury. Rats were prepared with tight ligation of the left L5-6 spinal nerves and chronic intrathecal catheter implantation. Tactile allodynia was measured by applying von Frey filaments ipsilateral to the lesioned hindpaw. Thresholds for paw withdrawal were assessed. Neostigmine (0.3-10 microg), muscimol (0.1-10 microg), and baclofen (0.1-3.0 microg) were administered to obtain the dose-response curve and the 50% effective dose (ED(50)). Fractions of ED(50) values were administered intrathecally to establish the ED(50)s of drug combinations (neostigmine-muscimol and neostigmine-baclofen). The drug interactions were performed. Intrathecal neostigmine, muscimol, baclofen, and their combinations produced a dose-dependent increase in withdrawal threshold of the lesioned hindpaw. Both analyses revealed a synergistic interaction for the neostigmine-muscimol combination, whereas the effect of the neostigmine-baclofen combination was additive. These results suggest that the activation of both muscarinic and GABA(A) receptors is required for synergistic interaction. IMPLICATIONS: This study indicates that drug interaction is synergistic for the neostigmine-muscimol combination, whereas the effect of the neostigmine-baclofen combination is additive. In a rat model of nerve ligation injury, neostigmine, muscimol, baclofen, and their combinations provide an antagonism on touch-evoked allodynia at the spinal level.


Subject(s)
Baclofen/pharmacology , Cholinesterase Inhibitors/pharmacology , GABA Agonists/pharmacology , Muscimol/pharmacology , Neostigmine/pharmacology , Neuralgia/drug therapy , Animals , Dose-Response Relationship, Drug , Drug Interactions , Hyperalgesia/drug therapy , Hyperalgesia/etiology , Ligation , Male , Neuralgia/etiology , Pain Threshold/drug effects , Rats , Rats, Sprague-Dawley , Spinal Nerves/surgery , Touch
20.
Pharmacol Toxicol ; 87(6): 261-8, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11140824

ABSTRACT

Tetrandrine, an alkaloid isolated from the Chinese medicinal herb Stephania tetrandra, has been shown to elicit antifibrotic effects in various cell types. In the present study, the effect of tetrandrine on liver fibrosis was investigated by using bile duct ligation and scission in rats as a model of hepatic fibrosis. Treatment with tetrandrine in fibrotic rats reduced serum aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase levels to 72%, 52% and 51% that of controls at 10 mg/kg/day, respectively. Liver hydroxyproline contents in tetrandrine-treated rats with bile duct ligation and scission were also reduced to 65% of that of control rats with bile duct ligation and scission at 10 mg/kg/day. The morphological characteristics of fibrotic liver, which appeared in control bile duct ligation and scission group, were improved in tetrandrine-treated bile duct ligation and scission group. We also examined the effect of tetrandrine on cultured rat hepatic stellate cells, which plays an important role in the pathogenesis of hepatic fibrosis, activation to investigate whether it could act mainly by direct action on rat hepatic fibroblastic cells. In cultured rat hepatic stellate cells, tetrandrine reduced DNA synthesis to 57% of control hepatic stellate cells at 10 microg/ml without affecting cell viability. Smooth muscle-alpha-actin expression, the phenotypic marker of activated hepatic stellate cells, was also decreased. We conclude that tetrandrine has an antifibrotic effect on liver fibrosis in rats induced by bile duct ligation and scission, indicating that it might exert a direct effect on rat hepatic stellate cells.


Subject(s)
Alkaloids/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Benzylisoquinolines , Liver Cirrhosis/drug therapy , Actins/metabolism , Animals , Bile Ducts/surgery , Cell Division/drug effects , Cell Survival/drug effects , Cells, Cultured , Cholestasis/physiopathology , Disease Models, Animal , Hepatocytes/drug effects , Hepatocytes/pathology , Ligation , Liver Cirrhosis/etiology , Liver Cirrhosis/pathology , Male , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL